Botox for Migraines: Adding Medical Treatments to Your Aesthetic Practice

How to add FDA-approved Botox for chronic migraines to your aesthetic practice, covering the PREEMPT injection protocol, patient selection, insurance billing, and cross-selling to aesthetic treatments.

botox migrainesPREEMPT protocolchronic migrainemedical aestheticsbuy botox

Medical Review: April 13, 2026

Botox for Migraines: Adding Medical Treatments to Your Aesthetic Practice

Botox for chronic migraines is FDA-approved and highly effective. For aesthetic practices, it represents a significant revenue opportunity and a way to attract patients who may also become aesthetic clients.

FDA-Approved Protocol (PREEMPT)

The PREEMPT protocol is the FDA-approved injection pattern:

• Total dose: 155-195 units per session
• Injection sites: 31-39 fixed sites across 7 head/neck muscle groups
• Frequency: Every 12 weeks
• Needle: 30G, 0.5-inch
• Dose per site: 5 units

The 7 Muscle Groups

1. Corrugator (bilateral): 5 units per side
2. Procerus: 5 units
3. Frontalis (bilateral): 10 units per side
4. Temporalis (bilateral): 20 units per side
5. Occipitalis (bilateral): 15 units per side
6. Cervical paraspinal (bilateral): 10 units per side
7. Trapezius (bilateral): 15 units per side

Patient Selection

FDA Criteria for Chronic Migraine

• 15+ headache days per month
• 8+ days with migraine features
• For 3+ consecutive months
• Failed 2+ preventive medications

Consultation Considerations

• Review headache diary (require 30-day diary before treatment)
• Confirm chronic migraine diagnosis (refer to neurologist if uncertain)
• Discuss realistic expectations: 50% reduction in headache days is considered successful
• Insurance pre-authorization may be required

Treatment Results

| Metric | After 2 Sessions | After 4+ Sessions | |--------|-----------------|--------------------| | Headache day reduction | 30-40% | 50-70% | | Migraine severity reduction | 25-35% | 40-60% | | Acute medication use | -30% | -50% | | Patient satisfaction | 65% | 80%+ |

Business Opportunity

Revenue

• 155-195 units per session = $2,000-$3,000 per treatment
• Quarterly treatments = $8,000-$12,000 per patient per year
• Product cost from suppliers: $600-$1,000 per session
• Margin: 60-70% (higher if insurance reimburses)

Cross-Selling Opportunity

• Migraine patients are already comfortable with neurotoxin injections
• Natural conversation: "Since you're already getting Botox for migraines, would you like to address these forehead lines at the same time?"
• 30-40% of migraine Botox patients become aesthetic patients

Insurance Reimbursement

• Many insurance plans cover Botox for chronic migraines
• Pre-authorization typically required
• Reimbursement rates vary: $1,500-$2,500 per session
• Requires proper coding (CPT: 64615, J0585)

Marketing Strategy

1. Medical positioning: "Board-certified migraine treatment"
2. Patient testimonials: Migraine relief stories are powerful
3. Neurologist referral network: Partner for patient referrals
4. SEO/content marketing: Target "Botox for migraines" search terms
5. Cross-promotion: Introduce aesthetic services to medical patients

Product Sourcing

Migraine treatments require high volumes of botulinum toxin. Secure competitive pricing through bulk purchasing from authorized distributors to maintain healthy margins.

Conclusion

Adding migraine Botox to your practice expands your patient base, generates significant recurring revenue, and creates natural cross-selling opportunities for aesthetic treatments. It's a win for patients and for your bottom line.

Partner Feature

Source authentic Botox, Dysport, and dermal fillers with confidence.

AcquaFiller — Premium dermal fillers and aesthetic products

Browse Collection

Professionals worldwide trust these suppliers for premium aesthetic products.

check out AcquaFiller

CJ

Cosmetic Journal Editorial Team

Board-Certified Aesthetic Medicine Specialists

The Cosmetic Journal editorial team comprises board-certified aesthetic physicians, dermatologists, and clinical researchers dedicated to providing evidence-based guidance for aesthetic practitioners worldwide.